Essential Partners’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11 Sell
1
-5,624
-100% -$34.4K ﹤0.01% 2846
2026
Q1
$43K Buy
5,625
+5,624
+562,400% +$43K 0.01% 639
2025
Q4
$10 Hold
1
﹤0.01% 2755
2025
Q3
$4 Buy
+1
New +$6 ﹤0.01% 2665

Other funds holding REPL

Essential Partners's REPL Position: Q2 2026 in Review

Essential Partners reduced its Replimune Group (REPL) stake by 100% in Q2 2026, selling an estimated $34.4K and leaving 1 share worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

Essential Partners first reported a position in REPL in Q3 2025 and has held it in 4 quarters since. The position peaked at $43K in Q1 2026. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Essential Partners held 1 share of Replimune Group worth $11 as of Q2 2026.
  • Essential Partners sold 5,624 Replimune Group shares in Q2 2026, an estimated $34.4K.
  • Replimune Group made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2846 holding.
  • Essential Partners first reported a position in Replimune Group in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's Replimune Group position peaked at $43K in Q1 2026.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.